Xeglyze™ (abametapir) – New drug approval
July 24, 2020 - The FDA approved Dr. Reddy’s Laboratories’ Xeglyze (abametapir), for the topical treatment of head lice infestation in patients 6 months of age and older. Xeglyze should be used in the context of an overall lice management program.
Download PDF
